C
Cytovance Biologics
Manufacturing and development services for recombinant protein drug substances
About Cytovance Biologics
Cytovance Biologics is a biopharmaceutical contract manufacturing organization (CMO) that focuses on the production of therapeutic proteins and antibodies. The company operates in the biopharmaceutical industry, serving clients that range from small biotech firms to large pharmaceutical companies. Cytovance Biologics specializes in both mammalian cell culture and microbial fermentation, including the production of plasmid DNA (pDNA). The company offers a comprehensive suite of services, including process development, cGMP (current Good Manufacturing Practice) manufacturing, and cGMP cell banking. These services are provided from their state-of-the-art facilities in Oklahoma City, which include extensive lab space and a newly constructed greenfield facility for GMP warehousing and future manufacturing expansions. Cytovance Biologics generates revenue through contract manufacturing agreements, where clients pay for the production and development of their biopharmaceutical products. The company has also been actively involved in the production and distribution of COVID-19 vaccines, contributing to the global effort to combat the pandemic.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Oct 2015 | $206M | $206M | Undisclosed | — |
| DEBT✓Debt | Oct 2014 | $20M | — | Monroe Capital | — |
Growth signals
Latest recorded traffic for Cytovance Biologics is 2.1K monthly website visits, down 30% over the last three months. Cytovance Biologics's team declined 25.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Cytovance Biologics in the Oklahoma City ecosystem
The Cytovance Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Great Point Partners
Monroe Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cytovance Biologics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cytovance Biologics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









